Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
CIS Is First in State to Use New Insertable Cardiac Monitor
06/20/2023

Cardiovascular Institute of the South Press Release

Cardiovascular Institute of the South...
June 20, 2023 – BATON ROUGE – Dr. Robert Drennan, electrophysiologist at Cardiovascular Institute of the South (CIS), is the first in the state to implant the Assert-IQ™ Insertable Cardiac Monitor, with advanced algorithms, remote...
June 20, 2023 – BATON ROUGE – Dr. Robert Drennan, electrophysiologist at Cardiovascular Institute of the South (CIS), is the first in the state to implant the Assert-IQ™ Insertable Cardiac Monitor, with advanced algorithms, remote...
June 20, 2023 – BATON ROUGE –...
06/20/2023
Vascular Disease Management

Advertisement

News
U.S. FDA Approves First Anti-Inflammatory Drug for Cardiovascular Disease
06/20/2023

AGEPHA Pharma Media

AGEPHA Pharma Media
Following a Priority Review, the U.S. FDA has approved LODOCO® as the first anti-inflammatory atheroprotective cardiovascular treatment demonstrated to reduce the risk of myocardial infarction (MI), stroke, coronary revascularization, and...
Following a Priority Review, the U.S. FDA has approved LODOCO® as the first anti-inflammatory atheroprotective cardiovascular treatment demonstrated to reduce the risk of myocardial infarction (MI), stroke, coronary revascularization, and...
Following a Priority Review, the...
06/20/2023
Cath Lab Digest
News
New Cardiovascular Horizons Conference Brings More Than 1320 to New Orleans
06/15/2023
NEW ORLEANS –More than 1,320 attended the New Cardiovascular Horizons (NCVH) conference at The Roosevelt New Orleans May 30-June 2 for a premier peripheral vascular disease program to improve cardiovascular care and outcomes in patients...
NEW ORLEANS –More than 1,320 attended the New Cardiovascular Horizons (NCVH) conference at The Roosevelt New Orleans May 30-June 2 for a premier peripheral vascular disease program to improve cardiovascular care and outcomes in patients...
NEW ORLEANS –More than 1,320...
06/15/2023
Vascular Disease Management
News
Dialysis Vascular Access Coalition (DVAC) Supports New Legislation to Stop Ongoing Cuts to Office-Based Specialists
06/15/2023
WASHINGTON, DC — Today, the Dialysis Vascular Access Coalition (DVAC) publicly supported the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674), introduced by Rep. Gus Bilirakis (R-FL-12), Rep. Tony Cardenas...
WASHINGTON, DC — Today, the Dialysis Vascular Access Coalition (DVAC) publicly supported the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674), introduced by Rep. Gus Bilirakis (R-FL-12), Rep. Tony Cardenas...
WASHINGTON, DC — Today, the...
06/15/2023
Cath Lab Digest

Advertisement

News
Study: Black Patients Nearly 50% Less Likely Than White Patients to Receive Vascular Interventions That Could Potentially Avoid Adverse Outcomes
06/14/2023
The study discovered that Black patients are more likely to only receive medication and lifestyle change recommendations, while white patients also receive revascularization.
The study discovered that Black patients are more likely to only receive medication and lifestyle change recommendations, while white patients also receive revascularization.
The study discovered that Black...
06/14/2023
Cath Lab Digest
News
Philips' Direct-to-Angio Stroke Pathway: New Analysis Demonstrates Substantial Cost Savings in Addition to Improved Patient Outcomes
06/14/2023
The retrospective analysis looked at data from the controlled single-center ANGIOCAT clinical trial conducted at the Vall d’Hebron University Hospital Stroke Unit (Barcelona, Spain) [1]. Earlier results from this study demonstrated that a...
The retrospective analysis looked at data from the controlled single-center ANGIOCAT clinical trial conducted at the Vall d’Hebron University Hospital Stroke Unit (Barcelona, Spain) [1]. Earlier results from this study demonstrated that a...
The retrospective analysis...
06/14/2023
Cath Lab Digest
News
DEEPER OUS Trial Evaluating Reflow Medical’s Bare Temporary Spur Stent System Shows Positive Results at 6 Months
06/12/2023
SAN CLEMENTE, Calif. -- June 12, 2023 -- Reflow Medical, Inc. announced the 6-month results of the DEEPER OUS clinical trial (NCT03807531) evaluating the safety and efficacy of the Bare Temporary Spur Stent System. Results were presented at...
SAN CLEMENTE, Calif. -- June 12, 2023 -- Reflow Medical, Inc. announced the 6-month results of the DEEPER OUS clinical trial (NCT03807531) evaluating the safety and efficacy of the Bare Temporary Spur Stent System. Results were presented at...
SAN CLEMENTE, Calif. -- June 12,...
06/12/2023
Vascular Disease Management

Advertisement

News
Endologix Receives FDA Approval of the DETOUR™ System to Treat Long Complex Superficial Femoropopliteal Lesions in Patients with PAD
06/08/2023
June 08, 2023 – IRVINE, Calif – Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, announced today that the U.S. Food and Drug...
June 08, 2023 – IRVINE, Calif – Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, announced today that the U.S. Food and Drug...
June 08, 2023 – IRVINE,...
06/08/2023
Vascular Disease Management
News
Digital Innovation Initiative Aims to Reduce Amputations
06/07/2023
June 07, 2023, RALEIGH, NC – In the United States alone, a leg is amputated every two minutes. As announced at last week's New Cardiovascular Horizons (NCVH) Annual Conference, this confronting statistic is being met head on by a digital...
June 07, 2023, RALEIGH, NC – In the United States alone, a leg is amputated every two minutes. As announced at last week's New Cardiovascular Horizons (NCVH) Annual Conference, this confronting statistic is being met head on by a digital...
June 07, 2023, RALEIGH, NC...
06/07/2023
Vascular Disease Management
BeGraft
News
Another Milestone Achieved – Bentley Sold Its 300,000th BeGraft
06/07/2023

Bentley Press Release 

Bentley Press Release 
Bentley, a leading manufacturer of balloon expandable covered stents, announced at the annual LINC meeting in Leipzig, Germany, that it has reached an important milestone having sold the 300,000th BeGraft.
Bentley, a leading manufacturer of balloon expandable covered stents, announced at the annual LINC meeting in Leipzig, Germany, that it has reached an important milestone having sold the 300,000th BeGraft.
Bentley, a leading manufacturer...
06/07/2023
Vascular Disease Management

Advertisement

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

Sleep and CVD
Study of Sleep in Women Shows Delaying Bedtime by Just 90 Minutes Each Night Damages Endothelial Cells
08/06/2024
After just six weeks of shortened sleep, the study found, the cells that line our blood vessels are flooded by damaging oxidants. And unlike well-rested cells, sleep-restricted cells fail to activate antioxidant responses to clear the...
After just six weeks of shortened sleep, the study found, the cells that line our blood vessels are flooded by damaging oxidants. And unlike well-rested cells, sleep-restricted cells fail to activate antioxidant responses to clear the...
After just six weeks of...
08/06/2024
Cath Lab Digest
Peripheral Interventions
VentureMed Completes Enrollment of the FLEX Vessel Prep System FLEX First AV Registry For The Treatment of Arteriovenous (AV) Access Management
07/30/2024
The FLEX Vessel Prep System has a unique non-balloon-based mechanism of action that creates longitudinal micro-incisions that release circumferential tension in diseased vessels. This release of tension is how FLEX modifies AV stenoses to...
The FLEX Vessel Prep System has a unique non-balloon-based mechanism of action that creates longitudinal micro-incisions that release circumferential tension in diseased vessels. This release of tension is how FLEX modifies AV stenoses to...
The FLEX Vessel Prep System has...
07/30/2024
Cath Lab Digest
Peripheral Interventions
Transit Scientific’s Novel XO Cath Microcatheter Breaks New Ground in Transradial Embolic Delivery Procedure
07/30/2024
​ Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, announced a milestone achievement with the successful utilization of XO Cath, its pioneering embolic delivery...
​ Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, announced a milestone achievement with the successful utilization of XO Cath, its pioneering embolic delivery...
​ Transit Scientific, a...
07/30/2024
Cath Lab Digest
Carotid Artery Revascularization
Silk Road Medical Celebrates Milestone of 100,000 Transcarotid Artery Revascularization (TCAR) Procedures
07/30/2024
Transcarotid Artery Revascularization (TCAR) is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a...
Transcarotid Artery Revascularization (TCAR) is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a...
Transcarotid Artery...
07/30/2024
Cath Lab Digest
Health Care Needs
JACC: Almost Half of U.S. Counties Have No Cardiologists Despite Higher Prevalence of CV Risk Factors, Mortality
07/29/2024
Upon analyzing all 3,143 U.S. counties, it was determined that 1,454 counties (46.3%) with 22 million residents had no cardiologists while the other 1,689 counties each had 24 cardiologists on average. 86.2% of rural counties had no...
Upon analyzing all 3,143 U.S. counties, it was determined that 1,454 counties (46.3%) with 22 million residents had no cardiologists while the other 1,689 counties each had 24 cardiologists on average. 86.2% of rural counties had no...
Upon analyzing all 3,143 U.S....
07/29/2024
Cath Lab Digest
Renal Denervation
First Patients Treated in Recor Medical’s Global Paradise System US Post Approval Study (US GPS) for the Treatment of Uncontrolled Hypertension With Ultrasound Renal Denervation
07/25/2024
The study will focus on gathering real-world safety and effectiveness data over five years from up to 1,000 patients, collaborating with research centers to help advance diversity and health equity within clinical trials. Building upon the...
The study will focus on gathering real-world safety and effectiveness data over five years from up to 1,000 patients, collaborating with research centers to help advance diversity and health equity within clinical trials. Building upon the...
The study will focus on...
07/25/2024
Cath Lab Digest
Ischemic Stroke
Imperative Care Announces Clinical Data from the Pivotal Imperative Trial Evaluating the Zoom Reperfusion System for the Treatment of Ischemic Stroke
07/24/2024
“The observed data showed all three pre-specified performance goals were met. These data suggest a lower rate of rescue therapy than prior thrombectomy trials and may demonstrate that intracranial positioning of a super-large bore catheter...
“The observed data showed all three pre-specified performance goals were met. These data suggest a lower rate of rescue therapy than prior thrombectomy trials and may demonstrate that intracranial positioning of a super-large bore catheter...
“The observed data showed all...
07/24/2024
Cath Lab Digest
LINC
News
HMP Global’s Leipzig Interventional Course (LINC) Announces 20th Anniversary Congress in January 2025
07/22/2024
LINC, the world’s premier interdisciplinary live course for vascular and endovascular teams, announced that its annual meeting is shifting from summer to winter, with its 20th anniversary Congress in January 2025.
LINC, the world’s premier interdisciplinary live course for vascular and endovascular teams, announced that its annual meeting is shifting from summer to winter, with its 20th anniversary Congress in January 2025.
LINC, the world’s premier...
07/22/2024
Vascular Disease Management
News
Life Seal Vascular Inc. Awarded Prestigious NSF SBIR Grant to Advance Innovative Endovascular Aortic Aneurysm Sac Management Technology
07/17/2024
More than $274,000 in NSF funding to develop breakthrough aneurysm sac management technology
More than $274,000 in NSF funding to develop breakthrough aneurysm sac management technology
More than $274,000 in NSF...
07/17/2024
Vascular Disease Management
Ischemic Stroke
Imperative Care Announces FDA Clearance and Initial Cases of the Zoom 6F Insert Catheters, the First Insert Catheters Built for Stroke
07/17/2024
Based on physician feedback, the new Zoom 6F Insert Catheters were developed to be more supportive, more torque-able and longer than current vessel selection devices and are offered in three stroke-specific shapes.
Based on physician feedback, the new Zoom 6F Insert Catheters were developed to be more supportive, more torque-able and longer than current vessel selection devices and are offered in three stroke-specific shapes.
Based on physician feedback, the...
07/17/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use